Detection of blood clots for assessing the risk of a heart attack
A new blood test is used to predict unwanted cardiovascular events in patients with developing coronary heart disease. This test measures the concentration of plasma tiles, a class of lipids that are closely linked to the progression of cardiovascular disease and is extremely useful for patients with coronary heart disease who show no improvement after treatment or for young patients with early coronary heart disease.
PATIENT COMES FIRST, HUMAN COMES FIRST
READ THE ARTICLE
This test helps clinicians identify people who are at risk for cardiovascular disease. It is also used to prescribe treatment, if necessary, to people at intermediate risk.
Blood plasma detection is a promising biomarker for predicting cardiovascular events in primary and / or secondary prevention.
Plasma blood count monitoring should be performed in conjunction with clinical evaluation and patient risk assessment to aid in predicting the risk of impending adverse cardiovascular events. The risks predicted by measuring tiles are independent of the classical biomarkers used, including age, sex, smoking, and history of coronary heart disease. Studies have shown that measuring plasma tiles can predict the likelihood of an adverse cardiovascular event within a year in patients with coronary heart disease, while in patients with suspected coronary heart disease and / or chronic heart failure, the test can predict the likelihood of an event within three to five years.
Sources: European Heart Journal, Canadian Journal of Cardiology, International Journal of Epidemiology